Cargando…
Propagermanium administration for patients with type 2 diabetes and nephropathy: A randomized pilot trial
AIMS: We assessed the potential efficacy and safety of propagermanium (PG), an organic compound that inhibits the C–C chemokine receptor type 2, administration in patients with type 2 diabetes and nephropathy. Furthermore, we assessed the feasibility of future studies. MATERIALS AND METHODS: We recr...
Autores principales: | Hara, Akinori, Shimizu, Miho, Hamaguchi, Erika, Kakuda, Hirokazu, Ikeda, Kenzo, Okumura, Toshiya, Kitagawa, Kiyoki, Koshino, Yoshitaka, Kobayashi, Motoo, Takasawa, Kazuya, Hisada, Yukimasa, Toyama, Tadashi, Iwata, Yasunori, Sakai, Norihiko, Wada, Takashi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7375122/ https://www.ncbi.nlm.nih.gov/pubmed/32704573 http://dx.doi.org/10.1002/edm2.159 |
Ejemplares similares
-
Age differences in the relationships between risk factors and loss of kidney function: a general population cohort study
por: Toyama, Tadashi, et al.
Publicado: (2020) -
Long-Term Outcomes of Japanese Type 2 Diabetic Patients With Biopsy-Proven Diabetic Nephropathy
por: Shimizu, Miho, et al.
Publicado: (2013) -
Association of renal arteriosclerosis and hypertension with renal and cardiovascular outcomes in Japanese type 2 diabetes patients with diabetic nephropathy
por: Shimizu, Miho, et al.
Publicado: (2019) -
Association between Unhealthy Dietary Habits and Proteinuria Onset in a Japanese General Population: A Retrospective Cohort Study
por: Tokumaru, Toshiaki, et al.
Publicado: (2020) -
Impact of the relationship between hemoglobin levels and renal interstitial fibrosis on long-term outcomes in type 2 diabetes with biopsy-proven diabetic nephropathy
por: Shimizu, Miho, et al.
Publicado: (2021)